• Language

  • English

Displaying results 13 - 24 of 69

Display:

12 24 48

Public Health and Advocacy

EASL Policy Dialogues S3 E8: Tackling Alcohol Harm: Lessons from Ireland and Europe

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues S3 E7: Transforming Liver Health in Europe: Policy, Prevention, and Cancer Screening Initiatives

EASL Policy Dialogues

View

General Hepatology

EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio

View

Viral Hepatitis

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF

View

COVID-19 and the liver

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF

View

Public Health and Advocacy

EASL Policy Statement on Liver Cancer Screening

PDF

View

Public Health and Advocacy

EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

PDF

View

Public Health and Advocacy

EASL Policy Statement on Screening of blood donations for hepatitis E virus (HEV)

PDF

View

Public Health and Advocacy

EASL Policy Statement on Reducing the burden of Alcohol Related Liver Disease (ARLD)

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - EN

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - EN

PDF

View

Displaying results 13 - 24 of 69

Display:

12 24 48